PHARM PUR GMBH has a total of 21 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Canada, Germany and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and machines are EASTERLING W JERRY, SEMMELWEIS UNIV and SENJU USA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | Germany | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Menz Dirk-Henning | 14 |
#2 | Dresp Joachim | 12 |
#3 | Kobuch Karin | 8 |
#4 | Hoerauf Hans | 7 |
#5 | Gabel Veit-Peter | 4 |
#6 | Kemnitz Erhard | 4 |
#7 | Menz Dirk Henning | 3 |
#8 | Gross Udo | 3 |
#9 | Winter Martin | 2 |
#10 | Menz Dirk-Hernning | 1 |
Publication | Filing date | Title |
---|---|---|
DE10123012C1 | Passivation of intraoccular lens, especially silicone, polymethyl methacrylate and acrylic intraoccular lens, comprises dipping in solution of fluoroalkyl-hydroxy- and/or -alkoxy-silane to deactivate Bronsted centers on surface | |
DE19926890C1 | Use of highly fluorinated oligomeric alkanes in ophthalmology, especially as vitreous humor substitutes, retinal tamponade materials, liquid implants, tear fluid substitutes and drug carriers | |
DE19811683A1 | Treatments for ophthalmology | |
DE19861012A1 | Ophthalmological use of fluorocarbon with low dissolved oxygen content, e.g. for treating ischemic retinal disease | |
DE19719280C1 | Fluorinated alkanes and their uses |